This study demonstrated the neuroprotective effects and underlying mechanism of BDNF‐AAV on motor and non‐motor symptoms in MPTP‐induced PD mice, suggesting that delivery BDNF in brain through AAV is a potential therapeutic strategy for the treatment of mitochondrial impairment‐associated neurodegenerative diseases. This evidence concerns the gene BDNF and neurodegenerative disease.